Clinical Trials

NCT06696768 | RECRUITING | PHASE1
24 participants

Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Bevacizumab) in Metastatic Colorectal Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-13
Start Date:
2025-06-23
Completion:
2026-12-31
Conditions
  • Metastatic Colorectal Adenocarcinoma
  • Stage III Colorectal Cancer AJCC v8
  • Stage IV Colorectal Cancer AJCC v8
  • Unresectable Colorectal Adenocarcinoma
Interventions
  • BIOLOGICAL
  • PROCEDURE
  • DRUG
No Results Yet
NCT06673329 | RECRUITING | PHASE1
11 participants

Brodalumab in the Treatment of Immune-Related Adverse Events

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-13
Start Date:
2025-03-11
Completion:
2027-05-31
Conditions
  • Breast Cancer
  • Esophageal Cancer
  • Kidney Cancer
  • Lung Cancer
  • Thyroid Cancer
  • Gynecologic Cancer
  • Pancreatic Cancer
  • Stomach Cancer
  • Brain Tumor
  • Colon Cancer
  • Rectal Cancer
  • Head and Neck Cancer
  • Oral Cancer
  • Liver Cancer
  • Skin Cancer
  • Prostate Cancer
  • Testicular Cancer
  • Solid Tumor
Interventions
  • DRUG
  • RADIATION
No Results Yet
NCT06654037 | RECRUITING | PHASE1
39 participants

Testing the Addition of an Anti-Cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (5-Fluorouracil) for Metastatic, Refractory Colorectal Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-13
Start Date:
2025-04-18
Completion:
2027-04-01
Conditions
  • Metastatic Microsatellite Stable Colorectal Carcinoma
  • Refractory Microsatellite Stable Colorectal Carcinoma
  • Stage IV Colorectal Cancer AJCC v8
Interventions
  • DRUG
  • PROCEDURE
No Results Yet
NCT06649812 | RECRUITING | PHASE2
120 participants

Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-13
Start Date:
2025-10-07
Completion:
2027-09-01
Conditions
  • High Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements
  • Recurrent Diffuse Large B-Cell Lymphoma
  • Recurrent Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type
  • Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
  • Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements
  • Recurrent High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements
  • Recurrent High Grade B-Cell Lymphoma, Not Otherwise Specified
  • Recurrent T-Cell/Histiocyte-Rich Large B-Cell Lymphoma
  • Refractory Diffuse Large B-Cell Lymphoma
  • Refractory Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type
  • Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
  • Refractory High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements
  • Refractory High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements
  • Refractory High Grade B-Cell Lymphoma, Not Otherwise Specified
  • Refractory T-Cell/Histiocyte-Rich Large B-Cell Lymphoma
Interventions
  • PROCEDURE
  • DRUG
  • BIOLOGICAL
No Results Yet
NCT06603363 | RECRUITING | NA
140 participants

Changes in Plaque Characteristics After Short-term Statin Therapy as Assessed With Coronary CT

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-13
Start Date:
2025-05-28
Completion:
2026-10-15
Conditions
  • Coronary Artery Disease
  • Atherosclerotic Plaque
  • Coronary Computed Tomography Angiography
  • Statin Therapy
  • Multidetector Computed Tomography
  • Heart Diseases
  • Cardiovascular Diseases
  • Arteriosclerosis
  • Vascular Diseases
  • Hyperlipidemia
Interventions
  • DRUG
  • DIAGNOSTIC_TEST
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page